Los Tres Paso Trial: Step One - Neoadjuvant Palbociclib Monotherapy, Step Two - Concurrent Chemoradiation Therapy, and Step Three - Adjuvant Palbociclib Monotherapy in Patients With p16INK4a Negative, HPV-Unrelated Head and Neck Squamous Cell Carcinoma
Phase of Trial: Phase II
Latest Information Update: 02 Oct 2018
At a glance
- Drugs Palbociclib (Primary) ; Cetuximab; Cisplatin
- Indications Head and neck cancer; Oropharyngeal cancer; Squamous cell cancer
- Focus Therapeutic Use
- Acronyms Los Tres Paso
- 31 Aug 2018 Biomarkers information updated
- 16 May 2018 According to the Pfizer media release, results from this trial will be presented at the 54th Annual Meeting of the American Society of Clinical Oncology (ASCO) 2018.
- 30 Apr 2018 Status changed from not yet recruiting to recruiting.